AnalystsMarc FrahmMarc Frahm's Stock Forecasts
AnalystsMarc Frahm
Sectors:
Industries:
Analyst Ranking
Bottom 7%
#4252 out of 4554 analysts
Average Return
-41.23%
Win Rate
0%0 out of 11
Risk vs Reward
Poor
Good
Marc Frahm's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
No Ratings AvailableMarc Frahm doesn't have any winning ratings in our database | |||||
Marc Frahm Analyst Color
Get additional color on Marc Frahm's coverage of popular stocks
Marc Frahm's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Incyte CorpINCY | 2 | Buy | $93.00 | +76.07% | Maintains | a year ago |
Imago Biosciences IncIMGO | 2 | Hold | $36.00 | N/A | Downgrades | a year ago |
Xilio Therapeutics IncXLO | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Theravance Biopharma IncTBPH | 1 | Hold | $14.00 | N/A | Downgrades | 3 years ago |
Nuvalent IncNUVL | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Elevation Oncology IncELEV | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Janux Therapeutics IncJANX | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Day One Biopharmaceuticals IncDAWN | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Constellation Pharmaceuticals IncCNST | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Inozyme Pharma IncINZY | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Black Diamond Therapeutics IncBDTX | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.